RIGL
Rigel Pharmaceuticals, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables):
amplitud de titulares +20.0% ·
flujo de acciones +26.6% ·
nuevas posiciones netas +16.7%
· fórmula
Acumulación amplia: acciones en aumento entre más titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | +1 | 535.68K | $25.79M | +1 | n/a |
| Q2 2026 | 72 | -2 | 9.47M | $370.29M | +3 | −5 |
| Q1 2026 | 77 | -10 | 11.13M | $301.00M | n/a | −10 |
| Q4 2025 | 86 | +1 | 11.49M | $491.92M | +1 | n/a |
| Q3 2025 | 18 | +3 | 6.87M | $194.53M | +3 | n/a |
| Q2 2025 | 12 | +2 | 4.47M | $83.70M | +2 | n/a |
| Q1 2025 | 7 | -1 | 1.55M | $27.81M | +2 | −3 |
| Q4 2024 | 8 | +4 | 1.41M | $23.66M | +5 | −1 |
| Q3 2024 | 3 | -2 | 554.02K | $8.97M | n/a | −2 |
| Q2 2024 | 5 | n/a | 605.71K | $4.98M | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (pasivo) | 1.72M | +6.1% | $48.87M | 0.0% | ▲ Add | 2 | SEC ↗ ×10 |
| 2 | The Vanguard Group ✦ (pasivo) | 1.04M | -0.9% | $29.55M | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 3 | Goldman Sachs Group ✦ | 737.03K | n/a | $20.88M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 4 | Marshall Wace ✦ | 601.33K | +63.0% | $17.04M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 5 | State Street Global Advisors ✦ (pasivo) | 554.32K | -7.6% | $15.70M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 6 | Renaissance Technologies ✦ | 474.21K | +100.6% | $13.43M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 7 | Geode Capital Management ✦ (pasivo) | 423.72K | +1.9% | $12.01M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 8 | D. E. Shaw & Co. ✦ | 306.49K | Nuevo | $8.68M | 0.0% | New | 1 | SEC ↗ ×2 |
| 9 | Two Sigma Investments ✦ | 220.30K | +474.6% | $6.24M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | Arrowstreet Capital ✦ | 186.33K | +747.6% | $5.28M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Morgan Stanley ✦ | 146.27K | n/a | $4.14M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 12 | Millennium Management ✦ | 105.30K | +236.9% | $2.98M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 86.46K | Nuevo | $2.45M | 0.0% | New | 1 | SEC ↗ ×2 |
| 14 | JPMorgan Chase ✦ | 69.92K | n/a | $1.98M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 15 | Wellington Management ✦ | 61.77K | -3.2% | $1.75M | 0.0% | ▼ Trim | 4 | SEC ↗ ×3 |
| 16 | Fidelity (FMR) ✦ | 59.09K | +1641.4% | $1.67M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 17 | AQR Capital Management ✦ | 56.60K | +463.9% | $1.60M | 0.0% | ▲ Add | 3 | SEC ↗ ×5 |
| 18 | T. Rowe Price ✦ | 9.29K | Nuevo | $264,000 | 0.0% | New | 1 | SEC ↗ |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| D. E. Shaw & Co. | $8.68M | 0.0% |
| Citadel Advisors | $2.45M | 0.0% |
| T. Rowe Price | $264,000 | 0.0% |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 146 tenedores, 15.81M acciones, $391.97M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.